Alexander Sasha Rackman, MD | |
880 Nw 13th St, Boca Raton, FL 33486-2342 | |
(561) 566-5328 | |
Not Available |
Full Name | Alexander Sasha Rackman |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 11 Years |
Location | 880 Nw 13th St, Boca Raton, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255775805 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Delray Medical Center | Delray beach, FL | Hospital |
Boca Raton Regional Hospital | Boca raton, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Florida Atlantic University | 8921097171 | 17 |
Florida Hospital Medicine Services, Llc | 7810129640 | 158 |
News Archive
The (Minneapolis-St. Paul) Star Tribune reports that hospitals in the Twin Cities appear to be back in the black after cutting jobs, freezing pay and delaying new construction on hospitals around the region.
Even premature babies carry anti-viral antibodies transferred from the mother, researchers at Karolinska Institutet in Sweden report in a paper on maternal antibodies in newborns, published in the journal Nature Medicine.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved SYNRIBO® (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and Instructions for Use.
Led by Lawson Health Research Institute, London Health Sciences Centre, University Health Network and General Dynamics Land Systems-Canada, researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization - the production of airborne respiratory droplets that may contain viruses or bacteria - when treating patients with COVID-19.
› Verified 2 days ago
Entity Name | Florida Atlantic University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164591954 PECOS PAC ID: 8921097171 Enrollment ID: O20040511001511 |
News Archive
The (Minneapolis-St. Paul) Star Tribune reports that hospitals in the Twin Cities appear to be back in the black after cutting jobs, freezing pay and delaying new construction on hospitals around the region.
Even premature babies carry anti-viral antibodies transferred from the mother, researchers at Karolinska Institutet in Sweden report in a paper on maternal antibodies in newborns, published in the journal Nature Medicine.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved SYNRIBO® (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and Instructions for Use.
Led by Lawson Health Research Institute, London Health Sciences Centre, University Health Network and General Dynamics Land Systems-Canada, researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization - the production of airborne respiratory droplets that may contain viruses or bacteria - when treating patients with COVID-19.
› Verified 2 days ago
Entity Name | Northeast Florida Hospitalists Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013036219 PECOS PAC ID: 2466544663 Enrollment ID: O20070817000145 |
News Archive
The (Minneapolis-St. Paul) Star Tribune reports that hospitals in the Twin Cities appear to be back in the black after cutting jobs, freezing pay and delaying new construction on hospitals around the region.
Even premature babies carry anti-viral antibodies transferred from the mother, researchers at Karolinska Institutet in Sweden report in a paper on maternal antibodies in newborns, published in the journal Nature Medicine.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved SYNRIBO® (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and Instructions for Use.
Led by Lawson Health Research Institute, London Health Sciences Centre, University Health Network and General Dynamics Land Systems-Canada, researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization - the production of airborne respiratory droplets that may contain viruses or bacteria - when treating patients with COVID-19.
› Verified 2 days ago
Entity Name | Florida Hospital Medicine Services, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508873183 PECOS PAC ID: 7810129640 Enrollment ID: O20140410000465 |
News Archive
The (Minneapolis-St. Paul) Star Tribune reports that hospitals in the Twin Cities appear to be back in the black after cutting jobs, freezing pay and delaying new construction on hospitals around the region.
Even premature babies carry anti-viral antibodies transferred from the mother, researchers at Karolinska Institutet in Sweden report in a paper on maternal antibodies in newborns, published in the journal Nature Medicine.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved SYNRIBO® (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and Instructions for Use.
Led by Lawson Health Research Institute, London Health Sciences Centre, University Health Network and General Dynamics Land Systems-Canada, researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization - the production of airborne respiratory droplets that may contain viruses or bacteria - when treating patients with COVID-19.
› Verified 2 days ago
Entity Name | Thema Brain Health Florida, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902684327 PECOS PAC ID: 4385091586 Enrollment ID: O20231109001670 |
News Archive
The (Minneapolis-St. Paul) Star Tribune reports that hospitals in the Twin Cities appear to be back in the black after cutting jobs, freezing pay and delaying new construction on hospitals around the region.
Even premature babies carry anti-viral antibodies transferred from the mother, researchers at Karolinska Institutet in Sweden report in a paper on maternal antibodies in newborns, published in the journal Nature Medicine.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved SYNRIBO® (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and Instructions for Use.
Led by Lawson Health Research Institute, London Health Sciences Centre, University Health Network and General Dynamics Land Systems-Canada, researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization - the production of airborne respiratory droplets that may contain viruses or bacteria - when treating patients with COVID-19.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Alexander Sasha Rackman, MD 880 Nw 13th St, Boca Raton, FL 33486-2342 Ph: (561) 566-5328 | Alexander Sasha Rackman, MD 880 Nw 13th St, Boca Raton, FL 33486-2342 Ph: (561) 566-5328 |
News Archive
The (Minneapolis-St. Paul) Star Tribune reports that hospitals in the Twin Cities appear to be back in the black after cutting jobs, freezing pay and delaying new construction on hospitals around the region.
Even premature babies carry anti-viral antibodies transferred from the mother, researchers at Karolinska Institutet in Sweden report in a paper on maternal antibodies in newborns, published in the journal Nature Medicine.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved SYNRIBO® (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and Instructions for Use.
Led by Lawson Health Research Institute, London Health Sciences Centre, University Health Network and General Dynamics Land Systems-Canada, researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization - the production of airborne respiratory droplets that may contain viruses or bacteria - when treating patients with COVID-19.
› Verified 2 days ago
Dr. Craig Michael Brodsky, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Nw 9th Ct, Suite 201, Boca Raton, FL 33486 Phone: 561-395-4600 Fax: 561-395-6903 | |
Dr. Sandra Luz Hirsch, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 660 Glades Rd, Ste 300, Boca Raton, FL 33431 Phone: 561-620-8992 Fax: 561-620-5815 | |
Dr. David John Alley, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 660 Glades Rd, Suite 140, Boca Raton, FL 33431 Phone: 561-447-7737 Fax: 561-447-9022 | |
Mrs. Mushfeka Moiz Golawala, M.D Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 20384 Hacienda Ct, Boca Raton, FL 33498 Phone: 561-703-1383 Fax: 561-423-8372 | |
Mohamed Atef Mohamed Elmahdy Hamed, Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-955-7100 | |
Craig L Stemmer, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 N Military Trl, Ste 195, Boca Raton, FL 33431 Phone: 561-241-7100 Fax: 561-241-3647 | |
Farid Assouad, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7777 Glades Rd, Ste 100, Boca Raton, FL 33434 Phone: 561-573-3495 Fax: 888-910-3040 |